Surgery Grand Rounds and Case Conference
December 4, 2013
Duke North – Room 2002
Surgical Grand Rounds
7:00 – 8:00 a.m.
“Multidisciplinary Treatment of Vascular Malformations:
The Duke Experience”
Cynthia E. K. Shortell, M.D.
Professor of Surgery
Chief, Vascular Surgery
Vice Chair, Faculty Affairs
Department of Surgery
Division of Vascular Surgery
Duke University Medical Center
Moderator: Mary E. Klotman, M.D.
Surgical Case Conference
8:00 – 9:00 a.m.
Moderator: Jeffrey H. Lawson, M.D., Ph.D.
Presenter Disclosure of Financial Relationships: Dr. Shortell indicates she has no financial relationships relative to the content presented and no personal/financial relationships to disclose which are relative to this activity. Dr. Klotman indicates she is an Advisory Board Member for Gilead and a Consultant for UpToDate, but has no personal/financial relationships to disclose which are relative to this activity. Dr. Lawson indicates that he is a Principal Investigator for Baxter, Humacyte, and Proteon; a Consultant for Cryolife and Hemoshpere; and a Speaker for W. L. Gore, but has no personal/financial relationships to disclose which are relative to this activity.
RSS Activity Medical Director(s) Disclosure: Dr. Ranjan Sudan has no personal/financial relationships to disclose which are relative to this activity.
---Global Learning Objectives---
- Review and discuss new advances in general surgery;
- Present and discuss case studies, protocols, treatment guidelines and surgical/pathology report appropriate to General Surgery practice;
- Review and discuss clinical research findings and other evidence from pertinent literature.
The Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
---Unapproved Use Disclosure---
Duke School of Medicine requires CME faculty (speakers) to disclose to the attendees: 1) When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (Not FDA approved) ; and 2) Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and /or unsupported opinion. Faculty at this event may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education, and is not intended to promote off-label use of these medications. If you have any questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
The Duke University School Of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in this activity.
In order to receive Credit, learners must sign in at the beginning of this event.
- 2.00 AMA PRA Category 1 Credit(s)™